Valion Bio, Inc. Debt Conversion, Converted Instrument, Amount
Valion Bio, Inc. (VBIO) reported Debt Conversion, Converted Instrument, Amount of $1.35 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2023-03-31
- Valion Bio, Inc. debt conversion, converted instrument, amount for the quarter ending 2021-12-31 was $0.00.
- Valion Bio, Inc. debt conversion, converted instrument, amount for the quarter ending 2021-09-30 was $248.00K.
- Valion Bio, Inc. debt conversion, converted instrument, amount for the quarter ending 2021-06-30 was $977.00K.
- Valion Bio, Inc. debt conversion, converted instrument, amount for the quarter ending 2021-03-31 was $130.00K.
- Valion Bio, Inc. debt conversion, converted instrument, amount for fiscal 2021 was $1.35M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $248.00K derived: sum of 2 quarters · filed 2023-03-31 | $1.23M derived: sum of 3 quarters · filed 2023-03-31 | $1.35M 10-K · filed 2023-03-31 |
| 2021-09-30 | $248.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.23M derived: sum of 2 quarters · filed 2022-11-14 | $1.35M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $977.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.11M 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $130.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |